Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CNK-UT cells in advanced solid tumors
NCT05976906Phase 1Unknown
- Sponsor
- Zhejiang University
- Start
- May 2023
- Primary completion
- May 2025
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial in solid tumor (advanced stage), sponsored by Zhejiang University. Primary endpoints: Incidence of Treatment Related adverse events at 1 year and Identification of Maximum Tolerated Dose & incidence of Dose-limiting Toxicities at 21 days. Status: unknown.
02
Conditions
solid tumor (advanced stage)
Beyond the preview
Go deeper on NCT05976906.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05976906.